RAF1 and glioblastoma: Following the identification of RAF1 upregulation in GBM tissues and astrocytes, our in-silico studies have demonstrated that RAF1 might be the direct target of hsa-miR-34a-5p and there is a significant negative correlation between RAF1 and hsa-miR-34a-5p in GBM tissues.